Table: Torii Pharmaceutical - 9-MTH parent results
Oct 29 (Reuters)-
Torii Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
9 months ended 9 months ended Year to
Sep 30, 2021 Sep 30, 2020 Dec 31, 2021
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 33.44 30.17 46.90
(+10.8 pct) (-3.7 pct) (+12.5 pct)
Operating 3.15 3.55 4.50
(-11.3 pct) (+436.5 pct) (-5.0 pct)
Recurring 3.26 3.75 4.70
(-13.2 pct) (+346.9 pct) (-5.5 pct)
Net 2.24 2.51 3.20
(-10.8 pct) (-90.5 pct) (-8.4 pct)
EPS 79.68 yen 89.34 yen 113.92 yen
EPS Diluted 89.33 yen
Ann Div 48.00 yen 48.00 yen
-Q2 div 24.00 yen 24.00 yen
-Q4 div 24.00 yen 24.00 yen
NOTE - Torii Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4551.T
Recent news on Torii Pharmaceutical Co
See all newsTable: Torii Pharmaceutical - 6-MTH parent results
Brief: Torii Pharmaceutical Co Ltd Says It Will Retire Treasury Shares Worth 2.39% Of Outstanding Stock On Aug 29
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Drugmaker Shionogi to buy Japan Tobacco's unit Torii Pharmaceutical for $1 billion (updated)